A Multicentre Pilot Study of a Two-Tier Newborn Sickle Cell Disease Screening Procedure with a First Tier Based on a Fully Automated MALDI-TOF MS Platform

The reference methods used for sickle cell disease (SCD) screening usually include two analytical steps: a first tier for differentiating haemoglobin S (HbS) heterozygotes, HbS homozygotes and β-thalassemia from other samples, and a confirmatory second tier. Here, we evaluated a first-tier approach...

Descripción completa

Detalles Bibliográficos
Autores principales: Naubourg, Pierre, El Osta, Marven, Rageot, David, Grunewald, Olivier, Renom, Gilles, Ducoroy, Patrick, Périni, Jean-Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510195/
https://www.ncbi.nlm.nih.gov/pubmed/33072970
http://dx.doi.org/10.3390/ijns5010010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510195/
https://www.ncbi.nlm.nih.gov/pubmed/33072970
http://dx.doi.org/10.3390/ijns5010010

Ejemplares similares